Advertisement

Topics

Astellas UK’s suspension from ABPI is extended for a year

10:08 EDT 23 Jun 2017 | EPM Magazine

A recent press release from the Association of the British Pharmaceutical Industry (ABPI) has announced that Astellas UK’s membership suspension has been extended for a further 12 months

Original Article: Astellas UK’s suspension from ABPI is extended for a year

NEXT ARTICLE

More From BioPortfolio on "Astellas UK’s suspension from ABPI is extended for a year"

Advertisement
Quick Search
Advertisement
Advertisement